Hammell DC - Search Results

1

Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.

Shin SH, Yu M, Hammell DC, Ghosh P, Raney SG, Hassan HE, Stinchcomb AL. Shin SH, et al. Among authors: hammell dc. J Control Release. 2022 Feb;342:134-147. doi: 10.1016/j.jconrel.2021.11.030. Epub 2021 Nov 25. J Control Release. 2022. PMID: 34838928

2

Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.

Stinchcomb AL, Swaan PW, Ekabo O, Harris KK, Browe J, Hammell DC, Cooperman TA, Pearsall M. Stinchcomb AL, et al. Among authors: hammell dc. J Pharm Sci. 2002 Dec;91(12):2571-8. doi: 10.1002/jps.10239. J Pharm Sci. 2002. PMID: 12434400

3

Human skin permeation of Delta8-tetrahydrocannabinol, cannabidiol and cannabinol.

Stinchcomb AL, Valiveti S, Hammell DC, Ramsey DR. Stinchcomb AL, et al. Among authors: hammell dc. J Pharm Pharmacol. 2004 Mar;56(3):291-7. doi: 10.1211/0022357022791. J Pharm Pharmacol. 2004. PMID: 15025853

4

In vitro/in vivo correlation studies for transdermal delta 8-THC development.

Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. J Pharm Sci. 2004 May;93(5):1154-64. doi: 10.1002/jps.20036. J Pharm Sci. 2004. PMID: 15067692

5

Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro.

Valiveti S, Kiptoo PK, Hammell DC, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. Int J Pharm. 2004 Jun 18;278(1):173-80. doi: 10.1016/j.ijpharm.2004.03.009. Int J Pharm. 2004. PMID: 15158959

6

A duplex "Gemini" prodrug of naltrexone for transdermal delivery.

Hammell DC, Hamad M, Vaddi HK, Crooks PA, Stinchcomb AL. Hammell DC, et al. J Control Release. 2004 Jun 18;97(2):283-90. doi: 10.1016/j.jconrel.2004.03.020. J Control Release. 2004. PMID: 15196755

7

Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation.

Valiveti S, Hammell DC, Earles DC, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. Pharm Res. 2004 Jul;21(7):1137-45. doi: 10.1023/b:pham.0000032999.31948.2e. Pharm Res. 2004. PMID: 15290852

8

Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.

Valiveti S, Nalluri BN, Hammell DC, Paudel KS, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Oct 25;810(2):259-67. doi: 10.1016/j.jchromb.2004.08.016. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 15380723

9

In vivo evaluation of 3-O-alkyl ester transdermal prodrugs of naltrexone in hairless guinea pigs.

Valiveti S, Hammell DC, Paudel KS, Hamad MO, Crooks PA, Stinchcomb AL. Valiveti S, et al. Among authors: hammell dc. J Control Release. 2005 Feb 2;102(2):509-20. doi: 10.1016/j.jconrel.2004.10.005. J Control Release. 2005. PMID: 15653167

10

Bioconversion of naltrexone and its 3-O-alkyl-ester prodrugs in a human skin equivalent.

Hammell DC, Stolarczyk EI, Klausner M, Hamad MO, Crooks PA, Stinchcomb AL. Hammell DC, et al. J Pharm Sci. 2005 Apr;94(4):828-36. doi: 10.1002/jps.20238. J Pharm Sci. 2005. PMID: 15736197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page